Structural and thermodynamic framework for PIEZO1 modulation by small molecules

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 120; no. 50; p. e2310933120
• Main Authors: Jiang, Wenjuan, Wijerathne, Tharaka D, Zhang, Han, Lin, Yi-Chun, Jo, Sunhwan, Im, Wonpil, Lacroix, Jerome J, Luo, Yun L
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 12.12.2023
• Subjects: Binding energy; Binding Sites; Biological Sciences; Channels; Crosslinking; Drug Discovery; Free energy; High-throughput screening; High-Throughput Screening Assays; Ion Channels - metabolism; Mechanotransduction, Cellular - physiology; Membrane proteins; Membranes; Modulators; Molecular dynamics; Pharmacology; Physical Sciences; Thermodynamics; alchemical free energy calculations; PIEZO1; agonist efficacy; Yoda1; mechanosensitive channel
• ISSN: 0027-8424; 1091-6490; 1091-6490
• DOI: 10.1073/pnas.2310933120

Mechanosensitive PIEZO channels constitute potential pharmacological targets for multiple clinical conditions, spurring the search for potent chemical PIEZO modulators. Among them is Yoda1, a widely used synthetic small molecule PIEZO1 activator discovered through cell-based high-throughput screening. Yoda1 is thought to bind to PIEZO1's mechanosensory arm domain, sandwiched between two transmembrane regions near the channel pore. However, how the binding of Yoda1 to this region promotes channel activation remains elusive. Here, we first demonstrate that cross-linking PIEZO1 repeats A and B with disulfide bridges reduces the effects of Yoda1 in a redox-dependent manner, suggesting that Yoda1 acts by perturbing the contact between these repeats. Using molecular dynamics-based absolute binding free energy simulations, we next show that Yoda1 preferentially occupies a deeper, amphipathic binding site with higher affinity in PIEZO1 open state. Using Yoda1's binding poses in open and closed states, relative binding free energy simulations were conducted in the membrane environment, recapitulating structure-activity relationships of known Yoda1 analogs. Through virtual screening of an 8 million-compound library using computed fragment maps of the Yoda1 binding site, we subsequently identified two chemical scaffolds with agonist activity toward PIEZO1. This study supports a pharmacological model in which Yoda1 activates PIEZO1 by wedging repeats A and B, providing a structural and thermodynamic framework for the rational design of PIEZO1 modulators. Beyond PIEZO channels, the three orthogonal computational approaches employed here represent a promising path toward drug discovery in highly heterogeneous membrane protein systems.